Pharmaco Imaging and Theranostic Agents — Year 2016 (Q3695265): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q3772056 / rank | |||
Normal rank | |||
Revision as of 18:35, 24 November 2021
Project Q3695265 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmaco Imaging and Theranostic Agents — Year 2016 |
Project Q3695265 in France |
Statements
182,127.0 Euro
0 references
404,728.53 Euro
0 references
45.0 percent
0 references
18 March 2016
0 references
31 October 2018
0 references
Université de Bourgogne
0 references
Le développement de nouveaux médicaments est un processus de plus en plus coûteux et compliqué sur le plan réglementaire comme technique; l’imagerie médicale dans ce contexte représente un axe stratégique pour l’économie. (French)
0 references
The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
18 November 2021
0 references
Identifiers
BG0005829
0 references